|Articles|November 1, 2003

Institutes to Develop Bioterrorism Vaccines

The University of Maryland School of Medicine will lead a multischool effort with 16 research institutions to develop vaccines to protect against bioterroism. The Middle Atlantic region will receive a 5-year, $42-million grant from the National Institute of Allergy and Infectious Diseases. Aside from creating vaccines to protect against anthrax, smallpox, and West Nile virus, they will study antibodies that could produce short-term protection. The regional researchers will study viruses that cause hemorrhagic fevers (eg, Ebola and Marburg viruses), as well as targeting Escherichia coli and Shigella. Also, they will design better diagnostic tests and needle-free vaccinations for fast response to a biological attack or infectious disease outbreak.

?The events of 9-11 [in 2001] and the anthrax threats that followed made it clear that there are nefarious people out there,? said Myron M. Levine, MD, who is the regional leader. ?We have also come to realize that we are extremely vulnerable and to a great extent unprepared for biological attacks. It is crucial for us to develop preventive vaccines to protect ourselves.?

Articles in this issue

almost 22 years ago

Article

Lack of Employment Raises Suicide Risk

almost 22 years ago

Article

Age-Related Dementia Traced to Viruses

almost 22 years ago

Article

Substance Abuse Linked with ADHD

almost 22 years ago

Article

Political Violence Has Lasting Effect

almost 22 years ago

Article

Outlook Is Positive for Getting Older

almost 22 years ago

Article

Mental Decline Goes Unnoticed

almost 22 years ago

Article

Diuretics Help Hips

almost 22 years ago

Article

Eye Disease Grows as Seniors Age

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Latest CME